Centre Hospitalier de Pau
About Centre Hospitalier de Pau
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Intergroupe Francophone de Cancerologie Thoracique
19
Federation Francophone de Cancerologie Digestive
10
Boston Scientific Corporation
9
University Hospital, Bordeaux
9
Centre Hospitalier de PAU
7
UNICANCER
7
European Organisation for Research and Treatment of Cancer - EORTC
6
Institut Bergonié
6
LivaNova
6
Nantes University Hospital
3
ARCAGY/ GINECO GROUP
2
Clinical Trials at Centre Hospitalier de Pau
During the past decade, Centre Hospitalier de Pau conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 14 clinical trials were completed, i.e. on
average, 19.4% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 10 clinical trials were completed. i.e. 52.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
1995-02-01
Completed
3,300
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1998-10-01
Active, not recruiting
1,649
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
2000-09-01
Unknown status
Combination Chemotherapy in Treating Women With Stage I Breast Cancer
2002-08-01
2013-06-01
Completed
1,512
Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer
2003-05-01
Completed
97
Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer
2002-06-01
Unknown status
Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
2004-12-01
2017-09-01
Completed
908
Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRT
2003-10-01
2005-12-01
Completed
172
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centre Hospitalier de Pau" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 19 trials, followed by "Federation Francophone de Cancerologie Digestive" with 10 trials
sponsored, "Boston Scientific Corporation" with 9 trials sponsored, "University Hospital, Bordeaux" with 9 trials sponsored and "Centre Hospitalier de PAU"
with 9 trials sponsored. Other sponsors include 92 different institutions and
companies that sponsored additional 65 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Pau"
#1 collaborator was "Ministry of Health, France" with 5 trials as a collaborator, "UNICANCER" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 64 different institutions and companies that were
collaborators in the rest 69 trials.
Clinical Trials Conditions at Centre Hospitalier de Pau
According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Pau" are
"Colorectal Cancer" (6 trials), "Coronary Artery Disease" (6 trials), "Breast Cancer" (5 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials) and "Heart Failure" (4 trials). Many other conditions were trialed in "Centre Hospitalier de Pau" in a lesser frequency.
Clinical Trials Intervention Types at Centre Hospitalier de Pau
Most popular intervention types in "Centre Hospitalier de Pau" are "Drug" (71 trials), "Device" (28 trials), "Procedure" (21 trials), "Other" (20 trials) and "Biological" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Carboplatin" (6 trials), "Bevacizumab" (5 trials), "Paclitaxel" (5 trials) and "fluorouracil" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Centre Hospitalier de Pau
The vast majority of trials in "Centre Hospitalier de Pau" are
137 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Centre Hospitalier de Pau
Currently, there are NaN active trials in "Centre Hospitalier de Pau".
3 are not yet recruiting,
21 are recruiting,
17 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 91 completed trials in Centre Hospitalier de Pau,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Centre Hospitalier de Pau, 0 "Phase 1"
clinical trials were conducted, 26 "Phase 2" clinical
trials and 47 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 13 trials, and there were
also 21 trials that are defined as “Not Applicable".
Departments of Centre Hospitalier de Pau
Centre Hospitalier de Pau has several departments that took part in Clinical trials: "Ch Francois Mitterrand; Medecine Oncologie" - 3 trials, "CH PAU - Service de Médecine interne et Maladies infectieuses" - 2 trials
Departments List